InvestorsHub Logo
icon url

Marty Byrd

10/26/19 8:13 PM

#17710 RE: stockguru1971 #17697

The question is : are they going to keep stem cells for FDA approved treatments? For example the recently announced trial for knee pain/OA. Thoughts?
icon url

dabonenose

10/27/19 9:53 AM

#17730 RE: stockguru1971 #17697

guru, I agree with most of your assessment, however Why can't PRED have both a growing Stem Cell and Woman's Health segments?

Stem Cells are still in their infancy as well as Endometriosis work.

Why not two divisions both with extremely high growth and Stem Cells has already proven lucrative.

Down the road after the stem cell biz is more valuable, sell it at that point. I would not underestimate the future strength in stem cells.

JMHO